Toxoplasma gondii IgG/IgM Test Device

Call For Pricing.

Model Number: NH-43827

Brand: Niche Healthcare

The TOXO IgG/IgM Rapid Test Device is a rapid chromatographic immunoassay for the qualitative detection of antibodies (IgG and IgM) to Toxoplasma gondii(Virus) in whole blood, serum or plasma to aid in the diagnosis of TOXO infection.

 

Description

Catalog No. TOXO-3022 Format Device
Specimen Whole blood/Serum/Plasma Certificate None CE
Reading Time 15 minutes Test/Kit 40
Storage Temperature 4-30°C Shelf Life 2 Years
Sensitivity >99.9% Specificity >99.9%
Accuracy >99.9% Composition Individually packed test device, Package insert, Dropper, Buffer

 

Toxoplasma gondii (TOXO) IgG/IgM Rapid Test Devices offer several healthcare benefits within the National Health Service (NHS) in the UK:

  1. Early Diagnosis: Rapid testing for Toxoplasma gondii IgG/IgM antibodies enables early detection of infection. This is particularly important for pregnant women, as timely diagnosis allows for appropriate management to reduce the risk of transmission to the fetus.

  2. Identification of Immune Status: The test distinguishes between IgG and IgM antibodies, providing information about the immune status of individuals. IgM antibodies typically indicate acute or recent infection, while IgG antibodies suggest past exposure and potential immunity.

  3. Risk Assessment in Pregnancy: For pregnant women, knowing their Toxoplasma gondii antibody status helps healthcare providers assess the risk of congenital toxoplasmosis transmission to the fetus. This information guides counseling and management decisions, such as the need for further testing and preventive measures.

  4. Prevention of Congenital Transmission: Timely identification of pregnant women who are susceptible to Toxoplasma gondii infection allows for appropriate counseling on preventive measures, such as avoiding exposure to contaminated soil, undercooked meat, and contact with cat feces, which can reduce the risk of congenital transmission.

  5. Reduced Anxiety and Uncertainty: Rapid test results provide reassurance to pregnant women and healthcare providers, alleviating anxiety and uncertainty associated with toxoplasmosis infection during pregnancy.

  6. Efficient Resource Utilization: Rapid testing facilitates efficient use of healthcare resources by streamlining diagnostic processes and reducing the need for additional confirmatory tests or unnecessary treatments in low-risk individuals.

  7. Public Health Surveillance: Rapid testing contributes to public health surveillance efforts by providing data on the prevalence of Toxoplasma gondii infection within the population, which can inform preventive strategies and healthcare policies.

  8. Improved Outcomes for Infected Individuals: Early detection of Toxoplasma gondii infection allows for timely initiation of treatment in symptomatic individuals, which can help prevent complications and improve clinical outcomes.

 

Infectious Disease Trials

Infectious disease trials are conducted to address various aspects related to the prevention, treatment, and understanding of diseases caused by infectious agents, such as bacteria, viruses, parasites, or fungi. Here are some reasons for conducting infectious disease trials:

  1. Vaccine Development: Trials are crucial for testing the safety and efficacy of new vaccines aimed at preventing infectious diseases. This includes vaccines for viruses like influenza, human papillomavirus (HPV), and emerging threats like COVID-19.
  2. Antiviral and Antibiotic Testing: Clinical trials assess the effectiveness of new antiviral medications or antibiotics in treating infections. This is particularly important in addressing antibiotic resistance and finding alternative treatments.
  3. Understanding Disease Mechanisms: Trials help researchers understand the mechanisms of infectious diseases, including how pathogens spread, evade the immune system, and cause illness.
  4. Global Health Concerns: Trials play a vital role in addressing global health concerns, such as emerging infectious diseases (e.g., Ebola, Zika, COVID-19) and ongoing challenges like malaria, tuberculosis, and HIV.
  5. Public Health Interventions: Trials evaluate the effectiveness of public health interventions, such as strategies for disease prevention, control, and containment.
  6. Drug and Treatment Development: Researchers conduct trials to develop and test new drugs or treatment regimens for infectious diseases, aiming to improve outcomes for affected individuals.
  7. Surveillance and Epidemiology: Clinical trials contribute to surveillance efforts by providing data on disease prevalence, transmission patterns, and the effectiveness of control measures.

Infectious disease trials are essential for advancing our understanding of these diseases, developing effective interventions, and ultimately improving global public health. They contribute significantly to the development of evidence-based strategies for preventing, treating, and managing infectious diseases.

 

Types of Infections

Types of Infections

 

For more information, contact us 01274 965089 or check out our website at www.nicheofficesolutions.co.uk www.nicheofficesolutions.co.uk/niche-nhs

Further clinical information can be found on our blog page: www.nicheofficesolutions.co.uk/category/niche-healthcare-news

For products not found on our online website, please view our Healthcare catalogues: www.nicheofficesolutions.co.uk/healthcare-catalogues

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at info@nicheofficesolutions.co.uk 

Reviews

There are no reviews yet.

Be the first to review “Toxoplasma gondii IgG/IgM Test Device”